✦ LIBER ✦

Erythropoietin adjuvant therapy and sustained virological response in HCV-infected patients

✍ Scribed by S.-M. Alavian; B. Behnava; S. V. Tabatabaei

Book ID: 108605987
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 56 KB
Volume: 32
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2010.04365.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained virological responses followin

Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients

✍ A. IACOBELLIS; M. SICILIANO; B. E. ANNICCHIARICO; M. R. VALVANO; G. A. NIRO; L. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

The effect of early virological response

The effect of early virological response in health-related quality of life in HCV-infected patients

✍ Lucas C. Quarantini; Ângela Miranda-Scippa; Susana Batista-Neves; Amanda Galvão- 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Twenty‐nine HCV‐infected patients were treated with pegylated interferon alpha. Diagnosis was based on serum HCV RNA‐PCR positive results and liver biopsy. All patients had elevated serum levels of alanine aminotransferase at the time of the study, but liver disease was compensated. Pat

A matched case-controlled study of 48 an

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response

✍ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Substitution of amino acid (aa) 70 and 91 in the core region of HCV genotype 1b is a useful pretreatment predictor of efficacy of 48‐week peginterferon (PEG‐IFN) plus ribavirin (RBV) therapy. Here, we determined the efficacy of 72‐week PEG‐IFN/RBV and the predictive factors to such ther

Predictors of sustained response to ther

Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy

✍ Nicola Gianotti; Alessandro Soria; Laura Galli; Antonella Castagna; Massimo Cern 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract In order to evaluate whether a sustained virologic response to therapy resumption after treatment interruption can be achieved in the setting of virologic failure, we reviewed retrospectively the data relating to 56 human immunodeficiency virus (HIV)‐infected subjects selected from 3,14

High baseline interleukine-8 level is an

High baseline interleukine-8 level is an Independent risk factor for the achievement of sustained virological response in chronic HCV patients

✍ Haji Akbar; Muhammad Idrees; Sadia Butt; Zunaira Awan; Muhammd Farooq Sabar; Irs 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Hepatitis C virus (HCV), a major cause of liver disease throughout the world, is difficult to treat with interferon (IFN) (and various formulations and combinations thereof) being the only approved molecule available. It has been investigated recently that proinflammatory chemokine interleukin-8 (IL

Sustained virological response to interf

Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: A retrospective study

✍ Savino Bruno; Tommaso Stroffolini; Massimo Colombo; Simona Bollani; Luisa Benveg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

The effect of achieving a sustained virological response (SVR) following interferon-␣ (IFN␣) treatment on the clinical outcomes of patients with HCV-related cirrhosis is unknown. In an attempt to assess the risk of liver-related complications, HCC and liver-related mortality in patients with cirrhos